AngioDynamics (NASDAQ:ANGO) Announces Quarterly Earnings Results

AngioDynamics (NASDAQ:ANGO) issued its earnings results on Wednesday. The medical instruments supplier reported $0.01 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.02) by $0.03, MarketWatch Earnings reports. The business had revenue of $72.80 million during the quarter, compared to analysts’ expectations of $67.33 million. AngioDynamics had a negative net margin of 62.90% and a positive return on equity of 0.18%. The business’s revenue for the quarter was up 4.0% compared to the same quarter last year. During the same period in the previous year, the company earned $0.06 earnings per share.

Shares of ANGO traded up $0.78 during mid-day trading on Friday, hitting $19.35. 4,161 shares of the company traded hands, compared to its average volume of 240,508. The company has a debt-to-equity ratio of 0.09, a quick ratio of 2.25 and a current ratio of 3.57. The stock has a 50-day moving average price of $14.29 and a two-hundred day moving average price of $11.16. AngioDynamics has a 1 year low of $7.48 and a 1 year high of $19.52. The stock has a market cap of $734.33 million, a price-to-earnings ratio of -4.37 and a beta of 0.89.

Several brokerages have issued reports on ANGO. Canaccord Genuity lifted their target price on shares of AngioDynamics from $14.00 to $18.00 and gave the stock a “hold” rating in a report on Friday. Raymond James boosted their price objective on shares of AngioDynamics from $18.00 to $24.00 and gave the company a “strong-buy” rating in a report on Friday. BidaskClub raised shares of AngioDynamics from a “hold” rating to a “buy” rating in a report on Wednesday. Finally, Zacks Investment Research cut shares of AngioDynamics from a “buy” rating to a “hold” rating and set a $15.00 price objective for the company. in a report on Tuesday, December 1st. Two investment analysts have rated the stock with a hold rating, two have given a buy rating and one has given a strong buy rating to the company. AngioDynamics currently has an average rating of “Buy” and an average target price of $19.00.

AngioDynamics Company Profile

AngioDynamics, Inc designs, manufactures, and sells various medical, surgical, and diagnostic devices for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors.

Read More: Circuit Breakers

Earnings History for AngioDynamics (NASDAQ:ANGO)

Receive News & Ratings for AngioDynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AngioDynamics and related companies with's FREE daily email newsletter.